Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Zogenix. Show all posts
Showing posts with label Zogenix. Show all posts
Wednesday, March 6, 2019

Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome

›
      Zogenix, Inc. (NASDAQ:ZGNX), a global pharmaceutical company developing rare disease therapies,  announced it has completed it...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.